Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo

Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo

Abstract Background Honokiol (HKL) has been reported to ameliorate lipopolysaccharide (LPS)-induced acute lung injury (ALI). However, its potential mechanism of its protective effects remains unclear. In this study, the protective mechanism of HKL on LPS-induced ALI was explored in vivo and in vitro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuhan Liu, Jiabin Zhou, Yingying Luo, Jinxiao Li, Luorui Shang, Fangyuan Zhou, Shenglan Yang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acute lung injury
Honokiol
NLRP3 inflammasome
Pyroptosis
Nrf2
Lipopolysaccharide
Other systems of medicine
RZ201-999
Acceso en línea:https://doaj.org/article/ef230416b9994822a6e9b831a8c47c7a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ef230416b9994822a6e9b831a8c47c7a

Ejemplares similares